Severe thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: A case report

Vox Sanguinis

Volumn 89, Issue 4, 2005, Pages 257-260

  Macher, Susanne ^a   Schallmoser, K ^a   Staber, P B ^a   Neumeister, P ^a   Posch, U ^a   Lanzer, G ^a   Panzer, S ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anti HPA 1a; HSCT; Non myeloablative; Thrombocytopenia

Indexed keywords

DNA; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; MONOCLONAL ANTIBODY; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN; THROMBOCYTE ANTIGEN HPA 1A; UNCLASSIFIED DRUG;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ARTICLE; CASE REPORT; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HLA MATCHING; HOST CELL; HUMAN; HUMAN CELL; MALE; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; SERUM; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ANTIGENS, HUMAN PLATELET; AUTOANTIBODIES; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLATELET TRANSFUSION; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 27844537781     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2005.00692.x     Document Type: Article

References (13)

1. Panzer S, Kiefel V, Bartram CR, Haas OA, Hinterberger W, Müller-Eckhardt C, Lechner K: Immune thrombocytopenia more than a year after allogeneic marrow transplantation due to antibodies against donor platelets with anti-PIA1 specificity: evidence for a host-derived immune reaction. Br J Haematol 1989; 71:259-264
2. a allo-antibody: presence of mixed chimerism 3 years after the graft without hematologic relapse. Blood 1994; 83:274-279
3. Taaning E, Jacobsen N, Morling N: Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation. Br J Haematol 1994; 86:651-653
4. Wernet D, Northoff H, Schnaidt M: Reactivation of antibodies of donor and recipient origin to platelet antigens early after allogeneic bone marrow transplantation: a case report. Br J Haematol 1994; 88:615-617
5. Niederwieser D, Maris M, Shizuru JA, Petersdorf E, Hegenbart U, Sandmaier BM, Maloney DG, Storer B, Lange T, Chauncey T, Deininger M, Pönisch W, Anasetti C, Woolfrey A, Little MT, Blume KG, McSweeney PA, Storb RF: Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003; 101:1620-1629
6. Kurz M, Knobl P, Kalhs P, Greinix HT, Hocker P, Panzer S: Platelet-reactive HLA antibodies associated with low post-transfusion platelet increments: a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test. Transfusion 2001; 41:771-774
7. British Committee for Standards in Haematology, Blood Transfusion Task Force: Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122:10-23
8. Kröger N, Schilling G, Einsele H, Liebisch P, Shimoni A, Nagler A, Perez-Simon JA, San Miguel JF, Kiehl M, Fauser A, Schwerdtfeger R, Wandt H, Sayer HG, Myint H, Klingemann H, Zabelina T, Dierlamm J, Hinke A, Zander AR: Deletion of chromosome band 13ql4 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation. Blood 2004; 103:4056-4061
9. French DL, Fruchtmann S, Beau Mitchell W, Coller BS, Peretz H: Evidence for megakaryocyte engraftment following reduced-intensity conditioning. Exp Hematol 2004; 32:877-880
10. Leitner GC, Stiegler G, Kalhs P, Greinix HT, Rabitsch W, Sillaber C, Höcker P, Panzer S: The influence of human platelet antigen match on the success of allogeneic peripheral blood progenitor cell transplantation following a reduced-intensity conditioning regimen. Transfusion 2005; 45:195-201
11. Leitner GC, Tanzmann A, Stiegler G, Kalhs P, Greinix HAT, Höcker P, Panzer S: Influence of human platelet antigen match on the success of stem cell transplantation after myeloablative conditioning. Bone Marrow Transplant 2003; 32:821-824
12. Garcia-Malo MD, Corral J, Gonzalez M, Solano C, Gonzalez-Conejero R, Caballero MD, Perez R, Moraleda JM, Vicente V: Human platelet antigen system in allogeneic peripheral blood progenitor cell transplantation: effect of human platelet antigen mismatch on platelet engraftment and graft-versus-host disease. Transfusion 2004; 44:771-776
13. Rozman P, Karas M, Kosir A, Labar B, Madrigal A, Middleton D, Navarrete C, Oudshoorn M, Schennach H, Vitek A, Bohinjec M: Collaborative Study. Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation? Bone Marrow Transplant 2003; 31:497-506